Drug – bio-affecting and body treating compositions – Solid synthetic organic polymer as designated organic active... – Polymer from ethylenic monomers only
Patent
1984-03-21
1985-10-15
Rose, Shep K.
Drug, bio-affecting and body treating compositions
Solid synthetic organic polymer as designated organic active...
Polymer from ethylenic monomers only
424 15, 424 19, 424 32, 424 81, A61K 926, A61K 944, A61K 3178
Patent
active
045473595
ABSTRACT:
A novel divisible delayed release pharmaceutical tablet, wherein the rate of release of active ingredient is independent of the size and nature of the total surface area, and the fragments of which have the same characteristics of release of active ingredient as the undivided tablet.
REFERENCES:
patent: 2987445 (1961-06-01), Levesque
patent: 3087860 (1963-04-01), Endigott
patent: 3390050 (1968-06-01), Speiser
patent: 3520970 (1970-07-01), Lehmann et al.
patent: 3608063 (1971-09-01), Banker
patent: 3629392 (1971-12-01), Banker et al.
patent: 3775537 (1973-11-01), Lehmann et al.
patent: 4013820 (1977-03-01), Farhadieh et al.
patent: 4083969 (1978-04-01), Inoue et al.
patent: 4152413 (1979-05-01), Goodnow
patent: 4152414 (1979-05-01), Harris et al.
patent: 4152415 (1979-05-01), Harris et al.
patent: 4223006 (1980-09-01), Taskis
patent: 4248855 (1981-02-01), Blank et al.
patent: 4343789 (1982-08-01), Kawata et al.
patent: 4351825 (1982-09-01), Sothmann et al.
patent: 4353887 (1982-10-01), Hess et al.
patent: 4357312 (1982-11-01), Hsieh et al.
patent: 4391797 (1983-07-01), Folkman et al.
patent: 4404183 (1983-09-01), Kawata et al.
Gupte Arun R.
Zierenberg Bernd
Boehringer Ingelheim KG
Rose Shep K.
LandOfFree
Divisible pharmaceutical tablet with delayed active ingredient r does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Divisible pharmaceutical tablet with delayed active ingredient r, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Divisible pharmaceutical tablet with delayed active ingredient r will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2431585